Hormone-Refractory Prostate Cancer Recruiting Phase 4 Trials for Enzalutamide (DB08899)

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030169 (Hormone-Refractory Prostate Cancer)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03016741Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate CancerSupportive Care